Epilutein for early-stage age-related macular degeneration: A randomized and prospective study
Ophthalmic Research Oct 16, 2017
Forte R, et al. - The proposition evaluated here was that oral supplementation of the epilutein/lutein combination could augment the macular pigment optical density (MPOD) in patients with age-related macular degeneration (AMD). An increased MPOD displayed a tie-up with the administration of lutein in combination with epilutein compared to the administration of lutein alone, in patients with early-stage AMD.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries